Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Cell Reports
|
February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growth
Avinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Plos Neglected Tropical Diseases
|
October 22, 2019
Dengue viral infection in Indonesia: Epidemiology, diagnostic challenges, and mutations from an observational cohort study
I Made Susila Utama, Nurhayati Lukman, Dewi Dian Sukmawati, et al.
Open Forum Infectious Diseases
|
January 29, 2021
Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection
Analia Uruena, Isabel Cassetti, Neena Kashyap, et al.
The Journal of Clinical Investigation
|
February 2, 2021
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
Kenta Matsuda, Stephen A Migueles, Jinghe Huang, et al.
The New Phytologist
|
August 18, 2022
Root biology never sleeps: 11<sup>th</sup> Symposium of the International Society of Root Research (ISRR11) and the 9<sup>th</sup> International Symposium on Root Development (Rooting2021), 24-28 May 2021
Clayton N Carley, Guanying Chen, Krishna K Das, et al.
The Lancet. Infectious Diseases
|
May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial
Emily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Annals of Internal Medicine
|
May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings
Michael C Sneller, C Jason Liang, Adriana R Marques, et al.
Wellcome Open Research
|
July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Biorxiv : the Preprint Server for Biology
|
April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines
Breanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Cell Reports
|
February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growth
Avinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Plos Neglected Tropical Diseases
|
October 22, 2019
Dengue viral infection in Indonesia: Epidemiology, diagnostic challenges, and mutations from an observational cohort study
I Made Susila Utama, Nurhayati Lukman, Dewi Dian Sukmawati, et al.
Open Forum Infectious Diseases
|
January 29, 2021
Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection
Analia Uruena, Isabel Cassetti, Neena Kashyap, et al.
The Journal of Clinical Investigation
|
February 2, 2021
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
Kenta Matsuda, Stephen A Migueles, Jinghe Huang, et al.
The New Phytologist
|
August 18, 2022
Root biology never sleeps: 11<sup>th</sup> Symposium of the International Society of Root Research (ISRR11) and the 9<sup>th</sup> International Symposium on Root Development (Rooting2021), 24-28 May 2021
Clayton N Carley, Guanying Chen, Krishna K Das, et al.
The Lancet. Infectious Diseases
|
May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial
Emily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Annals of Internal Medicine
|
May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings
Michael C Sneller, C Jason Liang, Adriana R Marques, et al.
Wellcome Open Research
|
July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Biorxiv : the Preprint Server for Biology
|
April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines
Breanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Page
of 8